DOUGLAS CLARK: Open Payments
NPI 1326038035 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,634 in 147 payments from 16 companies in 2025. Trend: 2023 $2,269 · 2024 $6,097 · 2025 $2,634
Food & beverage: $2,535Education: $99
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 29 | $500 |
| Lilly USA, LLC | 24 | $393 |
| Novartis Pharmaceuticals Corporation | 17 | $340 |
| LEO Pharma Inc. | 14 | $260 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $259 |
| ABBVIE INC. | 15 | $203 |
| Janssen Biotech, Inc. | 13 | $174 |
| GENZYME CORPORATION | 4 | $108 |
| Eli Lilly and Company | 1 | $99 |
| Galderma Laboratories, L.P. | 6 | $91 |
Products named: Bimzelx, TALTZ, COSENTYX, ILUMYA, TREMFYA, ANZUPGO, DUPIXENT, SKYRIZI.
Industry payments across AR — which companies pay providers there.
